STING1 and cancer: In the context of employing STING agonists for cancer therapy, it is crucial to ascertain the optimal timing, dosage, and frequency of administration to establish an effective therapeutic window, thereby mitigating the risk of immune exhaustion or toxic side effects due to overactivation.